218 related articles for article (PubMed ID: 10326025)
1. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
2. Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.
Tsujie M; Isaka Y; Nakamura H; Kaneda Y; Imai E; Hori M
Kidney Int; 2001 Apr; 59(4):1390-6. PubMed ID: 11260400
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
4. EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.
Otomo T; Yamamoto S; Morishita R; Kaneda Y
J Gene Med; 2001; 3(4):345-52. PubMed ID: 11529664
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
7. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
8. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
[TBL] [Abstract][Full Text] [Related]
9. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau VJ; Kaneda Y; Higaki J; Ogihara T
J Mol Cell Cardiol; 1997 Mar; 29(3):949-59. PubMed ID: 9152856
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
[TBL] [Abstract][Full Text] [Related]
11. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium.
Yonemitsu Y; Kaneda Y; Muraishi A; Yoshizumi T; Sugimachi K; Sueishi K
Gene Ther; 1997 Jul; 4(7):631-8. PubMed ID: 9282164
[TBL] [Abstract][Full Text] [Related]
12. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
13. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
[TBL] [Abstract][Full Text] [Related]
14. Using disaccharides to enhance in vitro and in vivo transgene expression mediated by a lipid-based gene delivery system.
Tseng WC; Tang CH; Fang TY; Su LY
J Gene Med; 2007 Aug; 9(8):659-67. PubMed ID: 17611953
[TBL] [Abstract][Full Text] [Related]
15. Time course of gene expression after plasmid DNA gene transfer to the liver.
Herweijer H; Zhang G; Subbotin VM; Budker V; Williams P; Wolff JA
J Gene Med; 2001; 3(3):280-91. PubMed ID: 11437333
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice.
Stoll SM; Sclimenti CR; Baba EJ; Meuse L; Kay MA; Calos MP
Mol Ther; 2001 Aug; 4(2):122-9. PubMed ID: 11482983
[TBL] [Abstract][Full Text] [Related]
18. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
[TBL] [Abstract][Full Text] [Related]
19. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
[TBL] [Abstract][Full Text] [Related]
20. A novel herpesvirus amplicon system for in vivo gene delivery.
Wang S; Di S; Young WB; Jacobson C; Link CJ
Gene Ther; 1997 Nov; 4(11):1132-41. PubMed ID: 9425435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
